| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $2.4B | $2.6B | $2.7B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.4B | — | — | — | — |
| Operating Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.3B |
| Net Income | $0.1B | $0.2B | $0.1B | $0.1B | $0.2B | $0.0B |
| EPS (Basic) | $3.66 | $4.63 | $3.02 | $1.90 | $3.69 | $0.60 |
| EPS (Diluted) | $3.59 | $4.53 | $2.98 | $1.90 | $3.67 | $0.60 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $1.6B | $1.5B | $1.5B | $1.5B | $1.6B | $1.3B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.1B | $0.2B | $0.1B | $0.2B | $0.0B |
| Total Liabilities | $0.9B | $0.9B | $0.9B | $0.9B | $0.9B | $0.3B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $0.7B | $0.7B | $0.6B | $0.6B | $0.7B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.1B | $0.2B | $0.2B | $0.2B | $0.5B |
| Investing Cash Flow | $0.0B | $-0.1B | $-0.0B | $-0.1B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B |
| Financing Cash Flow | $-0.1B | $-0.1B | $-0.1B | $-0.2B | $-0.0B | $-0.4B |